INTEGRATED BIOTHERAPEUTICS, LLC: federal contracts won
Federal contracts of $10,000 or more awarded to this company since October 2023 (FY2024), from USAspending.gov. UEI: XNTHMSN2JJP5
5contracts won
$172,792total obligated
$17,964median contract
Sep 01, 2026most recent start
Agencies it works for
| Agency | Contracts | Obligated |
|---|---|---|
| Department of Health and Human Services | 4 | $126,702 |
| Department of Veterans Affairs | 1 | $46,090 |
Industries (NAICS)
| NAICS | Contracts | Obligated |
|---|---|---|
| 541714 Research and Development in Biotechnology (except Nanobiotechnology) | 5 | $172,792 |
Where it works
Recent contracts
| Contract | Winner | Agency | Obligated | Start |
|---|---|---|---|---|
| THE PURPOSE OF THIS PURCHASE ORDER IS TO PROVIDE THE NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES (NIEHS) / DIVISION OF INTRAMURAL RE…
75N98026P01439 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Rockville, MD |
— | Department of Health and Human Services National Institutes of Health |
$75,000 | Sep 01, 2026 Ends: Aug 31, 2027 |
| MEDICAL R&D
36C24E26P0014 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Ann Arbor, MI |
— | Department of Veterans Affairs | $46,090 | Jun 22, 2026 Ends: Jun 21, 2027 |
| INTEGRATED BIOTHERAPEUTICS, INC.:1150828 [25-003252] LABORATORY AND TESTING SERVICES.
75N91025P00045 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Rockville, MD |
— | Department of Health and Human Services National Institutes of Health |
$17,964 | Feb 26, 2025 Ends: May 26, 2026 |
| THIS SERVICE IS NEEDED TO TEST THE EFFICACY A LAMBDA PHAGE VACCINE ENGINEERED WITH SEGMENTS OF THE COVID-19 SPIKE PROTEIN ANTIGEN IN AN ANIM…
75N91022P00832 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Rockville, MD |
— | Department of Health and Human Services National Institutes of Health |
$16,869 | Aug 28, 2022 Ends: Oct 16, 2022 |
| MOUSE EXPERIMENTS FOR OUR PHAGE-VECTOR CONSTRUCT OF A NEUROBLASTOMA VACCINE IS NEEDED TO TEST THE EFFICACY OF THE CONSTRUCT.
75N91022P00749 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Bethesda, MD |
— | Department of Health and Human Services National Institutes of Health |
$16,869 | Aug 10, 2022 Ends: Aug 09, 2023 |
Source: USAspending.gov (prime contract awards of $10,000 or more). Values are amounts obligated to date. Recent months can still change as agencies report late.